Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Caslake MJ, Packard CJ, Robertson M, Cooney J, Nelson JJ, Ford I, Gaw A, Jukema JW, Macfarlane PW, Stott DJ, Shepherd J; PROSPER Study Group. Caslake MJ, et al. Among authors: macfarlane pw. Atherosclerosis. 2010 May;210(1):28-34. doi: 10.1016/j.atherosclerosis.2009.10.041. Epub 2009 Nov 10. Atherosclerosis. 2010. PMID: 20005516
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.
Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Jukema JW, Hyland M, Gaw A, Lagaay AM, Perry IJ, Macfarlane PW, Meinders AE, Sweeney BJ, Packard CJ, Westendorp RG, Twomey C, Stott DJ. Shepherd J, et al. Among authors: macfarlane pw. Am J Cardiol. 1999 Nov 15;84(10):1192-7. doi: 10.1016/s0002-9149(99)00533-0. Am J Cardiol. 1999. PMID: 10569329 Clinical Trial.
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.
Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A. Freeman DJ, et al. Among authors: macfarlane pw. Circulation. 2001 Jan 23;103(3):357-62. doi: 10.1161/01.cir.103.3.357. Circulation. 2001. PMID: 11157685 Clinical Trial.
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk.
Houx PJ, Shepherd J, Blauw GJ, Murphy MB, Ford I, Bollen EL, Buckley B, Stott DJ, Jukema W, Hyland M, Gaw A, Norrie J, Kamper AM, Perry IJ, MacFarlane PW, Meinders AE, Sweeney BJ, Packard CJ, Twomey C, Cobbe SM, Westendorp RG. Houx PJ, et al. Among authors: macfarlane pw. J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):385-9. doi: 10.1136/jnnp.73.4.385. J Neurol Neurosurg Psychiatry. 2002. PMID: 12235304 Free PMC article. Clinical Trial.
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Among authors: macfarlane pw. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Sattar N, et al. Among authors: macfarlane pw. Circulation. 2003 Jul 29;108(4):414-9. doi: 10.1161/01.CIR.0000080897.52664.94. Epub 2003 Jul 14. Circulation. 2003. PMID: 12860911
Metabolic syndrome and diabetes mellitus.
Feeman WE Jr, Sattar N, OReilly DS, Packard CJ, Shepherd J, Gaw A, Macfarlane PW, Cobbe SM, Scherbakova O, Ford I, Haffner SM, Isles C. Feeman WE Jr, et al. Among authors: macfarlane pw. Circulation. 2004 Jan 27;109(3):E23. doi: 10.1161/01.CIR.0000113713.67092.C5. Circulation. 2004. PMID: 14744966 No abstract available.
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.
Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J; west of Scotland coronary prevention study. Sattar N, et al. Among authors: macfarlane pw. Diabetes. 2004 Nov;53(11):2855-60. doi: 10.2337/diabetes.53.11.2855. Diabetes. 2004. PMID: 15504965
327 results